会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • CELL-PERMEABLE ENDOSTATIN RECOMBINANT PROTEIN, A POLYNUCLEOTIDE COATED WITH THE SAME, AND AN ANTI-CANCER PREPARATION CONTAINING THE SAME AS AN ACTIVE COMPONENT
    • 细胞渗透性内切素重组蛋白,与其包被的多核苷酸,以及包含其作为活性成分的抗癌制剂
    • WO2009145489A2
    • 2009-12-03
    • PCT/KR2009001726
    • 2009-04-03
    • PROCELL THERAPEUTICS INCJO DAEWOONGLEE JONG MINPARK KYOUNGHODUONG MINH TAM
    • JO DAEWOONGLEE JONG MINPARK KYOUNGHODUONG MINH TAM
    • C07K19/00A61K38/17A61P35/00C07K14/47C12N15/62
    • C07K14/78A61K38/17C07K2319/01
    • The present invention relates to: a cell-permeable endostatin recombinant protein in which a macromolecule transduction domain (MTD) is fused to an angiogenesis inhibitor (angiogenic inhibitor) endostatin; a polynucleotide coated with the cell-permeable endostatin recombinant protein; an expression vector for the cell-permeable endostatin recombinant protein; and a pharmacological composition for an anti-cancer preparation with improved cancer angiogenesis inhibiting activity, which contains the cell-permeable endostatin recombinant protein as an active component. The cell-permeable endostatin recombinant protein according to the present invention can block the formation of microvessels and inhibit migration, proliferation, penetration, tube formation and the like of vascular endothelial cells present in tumor tissue by introducing angiogenesis inhibiting factor endostatin into the cell in a highly efficient fashion, and it exhibits outstanding anti-cancer activity and so can be used to good effect as an anti-cancer preparation used against various cancers.
    • 本发明涉及一种细胞可渗透的内皮抑素重组蛋白,其中大分子转导结构域(MTD)与血管发生抑制剂(血管生成抑制剂)内皮抑制素融合; 涂覆有细胞可渗透内皮抑素重组蛋白的多核苷酸; 用于细胞渗透性内皮抑素重组蛋白的表达载体; 以及具有改善的癌血管生成抑制活性的抗癌制剂的药理学组合物,其含有细胞可渗透的内皮抑素重组蛋白作为活性成分。 根据本发明的细胞可渗透的内皮抑素重组蛋白可通过将血管生成抑制因子内皮抑制素引入细胞中来阻断微血管的形成并抑制存在于肿瘤组织中的血管内皮细胞的迁移,增殖,穿透,管形成等 高效时尚,具有突出的抗癌活性,因此可用于作为抗癌制剂用于各种癌症的良好效果。